KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Change in Inventory (2016 - 2025)

Globus Medical (GMED) has disclosed Change in Inventory for 15 consecutive years, with $178000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Inventory fell 98.5% year-over-year to $178000.0, compared with a TTM value of $17.6 million through Dec 2025, down 41.06%, and an annual FY2025 reading of $17.6 million, down 41.06% over the prior year.
  • Change in Inventory was $178000.0 for Q4 2025 at Globus Medical, down from $5.7 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $22.5 million in Q1 2023 and bottomed at -$4.9 million in Q3 2024.
  • Average Change in Inventory over 5 years is $9.6 million, with a median of $10.2 million recorded in 2023.
  • The sharpest move saw Change in Inventory skyrocketed 565.12% in 2022, then plummeted 124.03% in 2024.
  • Year by year, Change in Inventory stood at $2.8 million in 2021, then skyrocketed by 366.01% to $13.1 million in 2022, then dropped by 13.33% to $11.4 million in 2023, then grew by 4.73% to $11.9 million in 2024, then tumbled by 98.5% to $178000.0 in 2025.
  • Business Quant data shows Change in Inventory for GMED at $178000.0 in Q4 2025, $5.7 million in Q3 2025, and $4.1 million in Q2 2025.